(Q36143394)

12 August 2017

1 reference

title

Combinatorial biomarkers: From early toxicology assays to patient population profiling (English)

1 reference

12 August 2017

0 references

Ronald Koop

1

1 reference

12 August 2017

publication date

1 June 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

10

1 reference

12 August 2017

issue

11

1 reference

12 August 2017

page(s)

781-788

1 reference

A new approach to decoding life: systems biology

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Systems biology: understanding cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

The impact of systems approaches on biological problems in drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Can complexity be commercialized?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Systems biology in drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Oncogenomics and the development of new cancer therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Cancer: understanding the target

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Moving towards individualized medicine with pharmacogenomics

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Toxicogenomics and systems toxicology: aims and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Toxicoproteomics: a parallel approach to identifying biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Toxicoproteomics: serum proteomic pattern diagnostics for early detection of drug induced cardiac toxicities and cardioprotection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Metabonomics: its potential as a tool in toxicology for safety assessment and data integration

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Metabolomics: what's happening downstream of DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Metabolomics in systems biology

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Toxicogenomics in drug discovery: from preclinical studies to clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

DNA microarrays as a tool in toxicogenomics

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Gene expression profiling reveals multiple toxicity endpoints induced by hepatotoxicants

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Gene expression profiling of rat livers reveals indicators of potential adverse effects.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Discriminating different classes of toxicants by transcript profiling

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Acute molecular markers of rodent hepatic carcinogenesis identified by transcription profiling

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Identification of platform-independent gene expression markers of cisplatin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Renal toxicogenomic response to chronic uranyl nitrate insult in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

The utility of DNA microarrays for characterizing genotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Database development in toxicogenomics: issues and efforts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Combined histomorphometric and gene-expression profiling applied to toxicology

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

The intelligent data management system for toxicogenomics

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Clofibrate-induced gene expression changes in rat liver: a cross-laboratory analysis using membrane cDNA arrays

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Cross-site comparison of gene expression data reveals high similarity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Interlaboratory evaluation of rat hepatic gene expression changes induced by methapyrilene

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Quantitative PCR deconstruction of discrepancies between results reported by different hybridization platforms

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

In silico prediction of drug toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

ADME-Tox in drug discovery: integration of experimental and computational technologies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Early prediction of drug metabolism and toxicity: systems biology approach and modeling

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

The in vitro micronucleus technique

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

High content screening applied to large-scale cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

From quantitative microscopy to automated image understanding

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Multidimensional drug profiling by automated microscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Protein biomarkers and drug design for cancer treatments

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Overview of treatment results with trastuzumab (Herceptin) in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

The efficacy of Herceptin therapies is influenced by the expression of other erbB receptors, their ligands and the activation of downstream signalling proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Cancer. A bull's eye for targeted lung cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Biomarkers of cancer risk and therapeutic benefit: new technologies, new opportunities, and some challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Genetic predictive factors in restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Serum proteomic patterns for detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Diverse proteomic alterations in gastric adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

DNA methylation markers in patients with gastrointestinal cancers. Current understanding, potential applications for disease management and development of diagnostic tools

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Laser capture microdissection, microarrays and the precise definition of a cancer cell

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Protein microarrays: meeting analytical challenges for clinical applications.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903440-9

7 January 2021

10.1016/S1359-6446(05)03440-9

Identifiers

DOI

1 reference

12 August 2017

1 reference